Concepedia

Deferoxamine Therapy

Deferoxamine Therapy is a chelation treatment that specifically involves the administration of deferoxamine, a selective iron-chelating agent, to remove excess iron from the body in cases of iron overload or poisoning.

948

Publications

52.3K

Citations

4.5K

Authors

1.3K

Institutions

Publications per year

2017–2026

164

Variants

Deferoxamine Treatment

Parents

Children

Publications

948

Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia Major

Gary M. Brittenham, Patricia Griffith, Arthur W. Nienhuis et al. · New England Journal of Medicine · 1994 · 846 citations · Full text

, , +16

Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells

Shumei Ma, Elizabeth S. Henson, Yongqiang Chen et al. · Cell Death and Disease · 2016 · 621 citations · Full text

, , +16

Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease

David Devos, Caroline Moreau, Jean Christophe Devedjian et al. · Antioxidants and Redox Signaling · 2013 · 613 citations · Full text

, , +17

Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenib

Christophe Louandre, Zakaria Ezzoukhry, Corinne Godin et al. · International Journal of Cancer · 2013 · 596 citations · Full text

, , +15

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

Bernadette Modell, Maren Khan, Matthew Darlison et al. · Journal of Cardiovascular Magnetic Resonance · 2008 · 590 citations · Full text

, , +16

1–5 of 948

Authors

4.5K

  1. JB
    John B. Porter

    University College London, United Kingdom

    31 publications · 2.4K citations

    25

    h-index

  2. GJ
    George J. Kontoghiorghes

    University College London, United Kingdom

    22 publications · 892 citations

    19

    h-index

  3. NF
    Nancy F. Olivieri

    Hospital for Sick Children, Canada

    19 publications · 2.4K citations

    18

    h-index

  4. AP
    Antonio Piga

    University of Turin, Italy

    20 publications · 2.1K citations

    17

    h-index

  5. MS
    Mohsen Saleh Elalfy

    Ain Shams University, Egypt

    19 publications · 1.1K citations

    17

    h-index

1–5 of 4.5K

Institutions

1.3K

  1. University College London

    London, United Kingdom

    39 h-index

    132 publications

    18.5K citations

  2. Ospedale Microcitemico

    Cagliari, Italy

    29 h-index

    79 publications

    10K citations

  3. Novartis (United States)

    New York, United States

    24 h-index

    54 publications

    5K citations

  4. Hospital for Sick Children

    Toronto, Canada

    23 h-index

    90 publications

    12K citations

  5. University of Toronto

    Toronto, Canada

    21 h-index

    76 publications

    4.4K citations

  6. Novartis (Switzerland)

    Basel, Switzerland

    21 h-index

    72 publications

    3.7K citations

  7. University of Michigan

    Ann Arbor, United States

    19 h-index

    91 publications

    7.7K citations

  8. Mahidol University

    Bangkok, Thailand

    19 h-index

    89 publications

    2.9K citations

1–8 of 1.3K

Venues

  1. PubMed

    Repository · 93 publications · 3.7K citations

    33

    h-index

  2. Blood

    42 publications · 3.6K citations

    26

    h-index

  3. British Journal of Haematology

    BJH · 28 publications · 2.2K citations

    24

    h-index

  4. European Journal Of Haematology

    26 publications · 1.7K citations

    22

    h-index

  5. Hemoglobin

    31 publications · 978 citations

    20

    h-index

1–5